WHAT: In February 2012 the ÐÇ¿Õ´«Ã½ System, through its Enterprise Investment Program, awarded medical device company EternoGen, LLC, up to $200,000 in seed funding. Since that initial funding, EternoGen has been able to leverage additional funds and meet major milestones that have advanced the commercialization of the company’s technology. The company plans to share these developments as well as the unique opportunities that EternoGen has in the bio-tech market.
WHEN: 10 a.m., CST, Tuesday, July 2, 2013
Opportunity for media following announcement
WHERE: MU Life Sciences Business Incubator at Monsanto Place
1601 S. Providence Rd., Columbia, Mo., 65211
Media who would like to attend the event are asked to RSVP to UM System Chief Communications Officer John Fougere no later than noon, Monday, July 1.
For St. Louis media:
WHAT: EternoGen will host a press conference in St. Louis following the Columbia event to introduce its management to the community and share its plans since receiving a $50,000 St. Louis Arch Grant.
WHEN: 3 p.m., CST, Tuesday, July 2, 2012
WHERE: Center for Emerging Technologies
4041 Forest Park Ave., St. Louis, Mo., 63108
Media who would like to attend the event are asked to RSVP to EternoGen CEO Luis Jimenez no later than 5 p.m., Monday, July 1, by emailing luis@eternogen.com.
Reviewed 2013-07-01